Get started
Danaher CorporationDanaher CorporationDanaher Corporation

Danaher Corporation

No trades
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsBondsETFs

Trade ideas

Danaher DHR at Gap Support Cepheid FDA Approved Coronavirus TestCepheid created a diagnostic test that could detect the novel coronavirus in approximately 45 minutes. This test was just approved by the FDA today. Also, Cepheid was just bought out by Danaher (DHR). This is why I'm doing an analysis for Danaher. Looking at the DHR stock, we see that it just reached the top of the gap that appeared in February 2019. If it goes below this gap, then we may see a gap fill which is why it's important to use a tight stop. However, I believe it is more likely, especially given the bullish catalyst, that we see the stock rise. My first target is right below the trapped longs. Anyone who bought in the red rectangle area, is praying for an exit. The more aggressive target (target 2) is a return to the top of the trend line. I realize this analysis is simple, but from my experience, it doesn't need to be more complicated. Check my most recent idea where I predicted the top of SPY to the dollar using a single trend line. Happy trading!
NYSE:DHRLong
by ttrending
3
$154 target for Danaher CorpAfter a great start to 2019 , DHR has stalled for the past 3 months and has been in a consolidation phase, we see a short term breakout above $145. Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following five segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products and services that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as to improve the aesthetics of the human smile. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.
NYSE:DHRLong
by Bullishcharts
$DHR WILL BE A GREAT SHORT ON ANY MARKET WEAKNESSDespite the acquisition of GE Biopharma the stock performance this year is hard to quantify, it does seem that it has ran a little too far to fast and needs a healthy pullback. We assume that when the selling does start it could snowball into quite a drop as large profits are banked and sellers find it hard to offload their portfolio. We will be looking at this as a short when the indicators become more oversld. AVERAGE ANALYSTS PRICE TARGET $144 AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT P/E RATIO 41 COMPANY PROFILE Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following five segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products and services that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as to improve the aesthetics of the human smile. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.
NYSE:DHR
by RedHotStocks
DHR Danaher Corp. Possible 10%+ Upside Trend/Resistance line: DHR Has recently overtaken a long-term resistance trendline starting in 2010 on the weekly chart and is currently using it as a loose support trendline. The chart, on both the weekly and daily timeframes, is showing an ascending wedge, with the stock gaining momentum we should see the price move past the resistance made in the 103.60-104.00 range. MACD (12, 26, close): The MACD indicator is showing a bullish signal on the weekly, assuming the current price action remains the same we should see this crossing be confirmed within the next two weeks. Not only does the weekly MACD look promising but the daily does as well, making higher bullish crossings, signaling increasing momentum. RSI(14): RSI on both daily and weekly have overtaken the 50 mark, again signaling the gain of momentum, which will be vital for breaking past resistance. FIB lines: Weekly fib lines have been marked on the chart, with the red being possible stops and green as my current price target, which loosely aligns with analyst recommendations. Daily chart supports these targets as well, although slightly lower at a price target of 108.00
NYSE:DHRLong
by odeaolay
1